EP.11D.01 A Phase II Study of Cadonilimab Plus Chemotherapy as First-Line Treatment for PD-L1-Negative Advanced Non-Small Cell Lung Cancer:LungCadX
Back to course
Pdf Summary
Asset Subtitle
Li Wang
Meta Tag
Speaker Li Wang
Topic Metastatic Non-small Cell Lung Cancer – Immunotherapy
Keywords
LungCadX
cadonilimab
chemotherapy
PD-L1-negative
NSCLC
progression-free survival
objective response rate
treatment-related adverse events
biomarkers
anti-tumor activity
Powered By